About Journal

Advancements in Bioequivalence & Bioavailability (ABB) is a online open access journal that mainly concentrates on publication of original research on bioequivalence and bioavailability, pharmacogenomics, pharmacodynamic and pharmacokinetic studies and its variations, drug efficacy, pharmacotherapeutics. The journal mainly focuses on the integration of new developments in the genome project and proteomics in clinical medicine, pharmacology and therapeutics, proteomics, new techniques that invented to study drug efficacy, stability and its applications, properties and functioning of drugs, dissolution rate, disintegration studies, genetic variability on drug toxicity and efficacy. It aims to publish highly effective papers related to all areas that come under bioequivalence and bioavailability. The journal has a proficiently supported and prominent editorial board. ABB offers a promising platform for researchers to publish their research papers and explore their inventions and knowledge. ABB publishes all types of articles like research, reviews, case reports, mini reviews, short communication, opinion, book reviews etc.

Latest Articles



About Crimson

We at Crimson Publishing are a group of people with a combined passion for science and research, who wants to bring to the world a unified platform where all scientific know-how is available read more...

Leave a comment

Contact Info

  • Crimson Publishers, LLC
  • 555 Madison Avenue, 5th floor
  •     New York, NY 10022, USA
  • +1 (929) 600-8049
  • +1 (929) 447-1137
  • info@crimsonpublishers.com
  • www.crimsonpublishers.com